14.37
+7.08%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Integra Lifesciences Holdings
From its filings with the US Securities and Exchange Commission
Integra Lifesciences Holdings is based in Princeton, New Jersey and is incorporated in Delaware. Its shares trade on Nasdaq under the ticker IART. The SEC classifies its business as surgical & medical instruments & apparatus. In the fiscal year to 31 December 2025, it reported revenue of $1.64bn and a net loss of $516.5m. At that date it held total assets of $3.60bn and shareholders' equity of $1.04bn. By business, Neurosurgery brought in 50.6% of revenue, followed by Wound Reconstruction and Care at 19.8% and Instruments at 12.6%. By region, United States accounted for 73.7%, followed by Asia Pacific at 11.6% and Europe at 9.9%.
Integra LifeSciences Holdings Corporation is a global medical technology company dedicated to restoring lives. We are advancing transformational care through impactful innovation and our portfolio of highly differentiated technologies is trusted by healthcare professionals to deliver transformative care.
We manufacture and sell medical technologies and products in two reportable business segments: Codman Specialty Surgical (“CSS”) and Tissue Technologies (“TT”). The CSS segment, which represents approximately 70% of our total revenue, consists of market-leading technologies and instrumentation used for a wide range of specialties, such as neurosurgery, neurocritical care, and otolaryngology, commonly referred to as ear, nose, and throat (“ENT”). We are the world leader in neurosurgery and one of the top three providers in the U.S. in instruments used in precision, specialty, and general surgical procedures. Our TT segment generates about 30% of our overall revenue and focuses on wound reconstruction and care and private label.
We offer leading technologies in dural repair, ultrasonic tissue ablation, intracranial pressure (“ICP”) monitoring, hydrocephalus management, and cranial stabilization systems, while providing a rich research and development pipeline for growth.
Quoted from its 10-K, filed 26 Feb 2026. Read the filing on SEC.gov ↗
Company facts
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Listed since
- 16 Aug 1995
- Employees
- 4,427
- Website
- integralife.com ↗
- Head office
- 1100 CAMPUS ROAD, PRINCETON, NJ, 08540
- Incorporated in
- DE
- Classification
- Surgical & Medical Instruments & Apparatus
- Filer status
- Large accelerated filer
Leadership
Pay as last reported
- Dr. Stuart EssigExecutive Chairman of the Board, since 1997$465,026
- Ms. Mojdeh PoulPresident, Chief Executive Officer, Director, since 2025
- Ms. Lea KnightChief Financial Officer, Executive Vice President$3.1m
- Ms. Chantal VeillonChief Human Resources Officer, Executive Vice President
- Mr. Eric SchwartzExecutive Vice President, Chief Legal Officer, Secretary$1.6m
- Mr. Robert DavisExecutive Vice President, President - Tissue Technologies$2.3m
- Mr. Michael McbreenExecutive Vice President, President - Codman Specialty Surgical$3.2m
- Mr. Harvinder SinghExecutive Vice President, President - International Business$2.6m
- Mr. Jeffrey MosebrookSenior Vice President - Finance, Principal Accounting Officer$1.3m
- Dr. Raymond TurnerCorporate Vice President, Chief Medical Officer
- Ms. Barbara HillIndependent Presiding Director$348,783
- Dr. Keith BradleyIndependent Director$295,009
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 61
- Environment
- 30
- Social
- 71
- Governance
- 82
- Direct emissions (scope 1)
- 8,277 t
- Energy emissions (scope 2)
- 15,333 t
- Value chain emissions (scope 3)
- 156,706 t
- Women in the workforce
- 48%
- Carbon reduction policy
- No
- Human rights policy
- Yes
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Integra Lifesciences Holdings Corp has a diverse product portfolio, catering to various medical needs and specialty segments. This allows the company to mitigate risks and maintain a stable revenue stream.
- With a strong focus on research and development, Integra Lifesciences continually introduces innovative products, enhancing its competitive advantage and establishing itself as a leader in the industry.
- The company has a global presence, with a wide distribution network, enabling it to reach a large customer base and generate significant sales.
Weaknesses
- Integra Lifesciences heavily relies on third-party suppliers for key components and raw materials, which may expose the company to supply chain disruptions and impact production capabilities.
- The company's high dependence on regulatory approvals for new product launches can cause delays and hinder its ability to quickly enter new markets.
- Integra Lifesciences has faced criticism related to product recalls and quality control issues. These incidents can damage the company's reputation and customer trust.
Opportunities
- The growing global healthcare industry presents Integra Lifesciences with opportunities to expand its product offerings and tap into emerging markets.
- Advancements in technology offer the company potential for developing and introducing new, more efficient medical devices and solutions that meet evolving customer needs.
- Strategic partnerships or acquisitions can help Integra Lifesciences strengthen its market position, gain access to new technologies, and expand its geographic presence.
Threats
- Intense competition within the medical technology industry poses a threat to Integra Lifesciences. Competitors with similar product offerings and established market presence can potentially capture market share.
- Changing regulations and reimbursement policies in the healthcare sector may impact the pricing and reimbursement of Integra Lifesciences' products, affecting its profitability.
- Global economic uncertainties, such as recessions or currency fluctuations, can affect the purchasing power of customers and consequently impact the demand for Integra Lifesciences' products.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.